Resonance Health patent granted
Thursday, 13 October, 2005
Perth based Resonance Health (ASX:RHT) has been granted its first European patent.
The patent protects the core invention underlying the FerriScan test for the non-invasive measurement of liver iron concentration. It is the European equivalent to a US patent granted in 2003 which is also being prosecuted in several other jurisdictions.
The company is also prosecuting a second patent family to expand the company's technology platform.
The intellectual property assets relating to the FerriScan test are fully owned by Resonance Health, following its acquisition of Inner Vision Biometrics in May 2005.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
